Transoral Robotic Surgery for Head and Neck Cancer Video - Brigham and Women's Hospital

1 Views

07/06/23

Dr. Donald Annino, Division of Otolaryngology at Brigham and Women's Hospital (BWH), demonstrates the use of transoral robotic surgery (TORS) to treat a patient with head and neck (oropharyngeal) cancer.

Brigham and Women's Hospital is one of only a few hospitals nationwide using state-of-the-art robotics to treat benign throat tumors and early-stage throat cancer. The potential of this unique technique to expand the scope of minimally invasive surgery and improve oncology treatment outcomes is motivating more and more of our patients to consider robotic surgery.

Head and neck (oropharyngeal) cancer is the sixth most common cancer in the U.S., with nearly 40,000 new cases diagnosed each year. Though tobacco and alcohol use can raise the risk of developing the disease, exposure to the human papillomavirus (HPV) poses an even greater risk. People who have had an oral HPV infection have a 50 times greater risk of developing cancer versus the general population. Currently, nearly three quarters of head and neck tumors test positive for HPV. A growing number of cases are being diagnosed among men in their forties and fifties.

Learn more about TORS at Brigham and Women's Hospital:
https://www.brighamandwomens.o....rg/surgery/otolaryng